Skip to content

Clinical trials

Huntington Disease trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Huntington Disease Country / region: United Kingdom Clear all

51 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20081
20093
20113
20121
20144
20154
20174
20182
20193
20204
20213
20226
20235
20242
20251
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23
Recruiting9
Terminated9
Unknown status6
Active, not recruiting4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche6
Wave Life Sciences USA, Inc.5
CHDI Foundation, Inc.4
Novartis Pharmaceuticals4
Prilenia4
European Huntington's Disease Network2
Pfizer2
Supernus Pharmaceuticals, Inc.2
Teva Branded Pharmaceutical Products R&D, Inc.2
University College, London2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Huntington Disease51
Chorea4
Neurodegenerative Diseases3
Rare Diseases2
Anxiety Disorders1
Dyskinesias1
Machado-Joseph Disease1
Spinocerebellar Ataxias1
Spinocerebellar Degenerations1
Tourette Syndrome1

Trials

Showing 76 to 51 of 51. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.